Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 14, 2014; 20(26): 8341-8350
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8341
Published online Jul 14, 2014. doi: 10.3748/wjg.v20.i26.8341
Lifestyle intervention |
Calorie restriction |
Mediterranean diet |
Exercise |
Medication |
Weight loss drugs |
Orlistat |
Sibutramine |
Antidiabetics |
Metformin |
Pioglitazone |
DPP IV inhibitors |
GLP-1 receptors agonists |
Antioxidants |
Vitamin E |
Statins |
Pravastatin |
Pitavastatin |
Atorvastatin |
Rosuvastatin |
PUFA |
Vitamin D |
UDCA |
Probiotics |
Berberine |
Silymarin |
Silybin |
Bariatric surgery |
Overweight and obesity |
Sedentary lifestyles |
Insulin resistance |
Oxidative stress |
Atherogenic dyslipidemia |
Vitamin D deficiency |
Hepatocyte protection |
Cardiovascular risk |
Treatment of comorbidities |
Mitochondrial dysfunction |
- Citation: Ben MD, Polimeni L, Baratta F, Pastori D, Loffredo L, Angelico F. Modern approach to the clinical management of non-alcoholic fatty liver disease. World J Gastroenterol 2014; 20(26): 8341-8350
- URL: https://www.wjgnet.com/1007-9327/full/v20/i26/8341.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i26.8341